Can the U.S. and Iran turn the temporary ceasefire into long-term peace? President Trump finds an off-ramp to the five-week war in Iran, but at what cost? He began the week threatening Iran's “whole ...

YouTube has evolved a lot since Google bought the platform. It hasn't become better in all respects, though. Parts of it are way better than they ever were, a small part of it has gotten worse, and ...

Compass sued Zillow in June over its listing access standards, which threatened to ban listings that were not uploaded to its platform within 24 hours of being publicly marketed. Last month, a judge ...

Property brokerage Compass on Wednesday dropped its lawsuit against Zillow, ending a legal clash over how home listings can be marketed online. For the past few years, Compass — now the largest real ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Compass International Holdings (CIH), the parent company of real estate brokerage Compass, is teaming up with Rocket Companies and Redfin to display its Compass Coming Soon listings for Redfin’s 60 ...

Compass Coffee, the beleaguered D.C.-based chain, has a new owner. Elizabeth L. Gunn, a U.S. bankruptcy judge for the District of Columbia, approved the sale Thursday to London-based giant Caffè Nero, ...

Kanen bought 1,573,950 Compass shares; estimated trade size $14.36 million based on quarterly average price. Quarter-end Compass position value rose by $29.11 million, reflecting both trading and ...

Phase 3 clinical trial data has been a success. COMP360 is the first traditional psychedelic to consistently deliver a highly statistically significant outcome. Results included maintaining a ...

COMP360 shows rapid symptom improvement in depression study COMP360 may compete with J&J's Spravato if approved Compass plans FDA meeting for rolling submission Feb 17 (Reuters) - Compass Pathways ...